AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 6233148
Drug: Piracetam (administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Piracetam (administered intravenously)
Trial: 22180633
Drug: ANA 150
RxNorm normalized name: Ana-Lex
DrugBank: Hydrocortisone acetate (DB14539)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: ANA 150 mg/day
Trial: 22180633
Drug: ANA 20
RxNorm normalized name: Ginsana 200mg Softgel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ANA 20 mg/day
Trial: 19906799
Drug: Seasonally adjusted
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Seasonally adjusted 25(OH)D concentration <50 nmol/L
Trial: 16129989
Drug: Tramadol (mean
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tramadol (mean dose 448 mg)
Trial: 16129989
Drug: Amitriptyline (mean
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amitriptyline (mean dose 55 mg)
Trial: 12006895
Drug: Fluoxetine (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluoxetine (20 mg for the first 8 weeks, then increased by 20 mg every two weeks to a maximum of 60 mg/day)
Trial: 25700621
Drug: DY-807f (360
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DY-807f (360 mg)
Trial: 25700621
Drug: DY-807f (60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DY-807f (60 mg)
Trial: 25700621
Drug: DY-807f (various
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DY-807f (various doses: 10, 30, 60, 120, 240, 360 mg)
Trial: 24423149
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg saxagliptin for 6 weeks
Trial: 17518968
Drug: Home visits
RxNorm normalized name: benzalkonium
DrugBank: Benzalkonium (DB11105)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Home visits for advising mothers about breastfeeding and weaning; Duration: 10 days after birth, monthly up to 6 months, at 8, 10, and 12 months; Based on 'Ten Steps for Healthy Feeding'
Trial: 15601310
Drug: Troxerutin (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Troxerutin (50 mg) and Zn gluconate (25 mg)
Trial: 15601310
Drug: Control treatment
RxNorm normalized name: SALICYLIC ACID 190 mg in 1 mL TOPICAL LIQUID [Derma E Acne Blemish Control Treatment Serum]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control treatment with 10 mg Zn gluconate
Trial: 12489528
Drug: Therapeutic Play
RxNorm normalized name: Moisturel Therapeutic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Therapeutic Play preparation
Trial: 12489528
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no Therapeutic Play preparation)
Trial: 9774209
Drug: 6.8 g/100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6.8 g/100 ml commercial carbohydrate‐electrolyte (CHO) beverage (39 +/‐ 4 g of CHO)
Trial: 8151323
Drug: DTIC 800
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DTIC 800 mg/m2 IV days 1 and 21
Trial: 8151323
Drug: DTIC plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DTIC plus rIFN alpha 2a 9 mIU IM daily
Trial: 24108515
Drug: Crystalloids (isotonic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Crystalloids (isotonic or hypertonic saline or Ringer lactate solution)
Trial: 19630069
Drug: Emotion Regulation
RxNorm normalized name: benzalkonium
DrugBank: Benzalkonium (DB11105)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Emotion Regulation Training (ERT) plus treatment as usual (TAU)
Trial: 11798216
Drug: Application of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Application of the WHO analgesic ladder, appropriate opioid dose escalation, use of adjuvant analgesics, and non-pharmacological methods of pain control
Trial: 31629060
Drug: Darbepoetin alfa
RxNorm normalized name: Darbepoetin Alfa
DrugBank: Darbepoetin alfa (DB00012)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Darbepoetin alfa (500 μg every 3 weeks)
Trial: 30257178
Drug: Brief Intervention
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Brief Intervention (BI) for illicit drug use linked to ASSIST
Trial: 16143732
Drug: Telephone-administered supportive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Telephone-administered supportive emotion-focused therapy (Control)
Trial: 11812697
Drug: lidocaine 1%
RxNorm normalized name: LIDOCAINE 1% LOTION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: lidocaine 1% (L)
Trial: 11812697
Drug: lidocaine 1%
RxNorm normalized name: LIDOCAINE 1% LOTION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: lidocaine 1% and sodium bicarbonate 8.4% (L+BIC)
Trial: 11812697
Drug: normal saline
RxNorm normalized name: Normal Saline Flush
FDA approved: no
EMA approved: no
PMDA approved: no
Description: normal saline solution 0.9% (NSS)
Trial: 8722349
Drug: G-CSF +
RxNorm normalized name: G-CSF
DrugBank: Lenograstim (DB13144)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: G-CSF + Epo (150 U/kg, from day +1 to +21)
Trial: 8722349
Drug: G-CSF (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: G-CSF (5 micrograms/kg, from day +1 up to reaching an ANC > or = 10(9)/1)
Trial: 8722349
Drug: Control (neither
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (neither G-CSF nor Epo)
Trial: 2060514
Drug: All agents
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All agents (Cefoperazone, Ceftizoxime, Ceftriaxone)
Trial: 2060514
Drug: Ceftriaxone (once
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ceftriaxone (once daily vs twice daily)
Trial: 2060514
Drug: All three
RxNorm normalized name: three-lobe sage extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: All three agents
Trial: 6337428
Drug: Aspirin (325
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin (325 mg) plus placebo four times daily
Trial: 27393722
Drug: Variable-time dosing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Variable-time dosing of basal insulin peglispro (BIL)
Trial: 27393722
Drug: Fixed-time dosing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fixed-time dosing of basal insulin peglispro (BIL)
Trial: 23184419
Drug: Potassium binoxalate
RxNorm normalized name: Potassium
DrugBank: Potassium (DB14500)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Potassium binoxalate gel (group A, 40 teeth)
Trial: 23184419
Drug: Nd:YAG laser
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nd:YAG laser (group B, 40 teeth: 1 W, 10 Hz, 60 s, irradiated twice)
Trial: 17268158
Drug: Low-dose milrinone
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose milrinone (25 microg/kg loading dose, followed by 0.25 microg/kg/min maintenance)
Trial: 17268158
Drug: Low-dose milrinone
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose milrinone
Trial: 7241441
Drug: Methohexitone administered
RxNorm normalized name: Methohexitone
DrugBank: Methohexital (DB00474)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Methohexitone administered in increments based on body weight and time, with suxamethonium for relaxation.
Trial: 7241441
Drug: Small aliquots
RxNorm normalized name: smallpox vaccine live, New York City Board of Health vaccinia strain Injectable Solution [ACAM2000]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Small aliquots of lignocaine for reducing injection pain, given before or mixed with methohexitone.
Trial: 31940502
Drug: Inhaled nitric
RxNorm normalized name: nitric oxide Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled nitric oxide (NO) + O2 for 24 hours
Trial: 31017569
Drug: Vitamin B
RxNorm normalized name: VITAMIN B
DrugBank: Inositol (DB13178)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vitamin B complex added to prime solution for CPB (25 mg vitamin B1, 2.734 mg vitamin B2, 5 mg vitamin B6, 15 mcg vitamin B12, 50 mg niacinamide, 17.2 mg D-panthenol)
Trial: 24270456
Drug: Concurrent Strength
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Concurrent Strength and Endurance Training ratio 3:1 (CT3)
Trial: 24270456
Drug: Concurrent Strength
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Concurrent Strength and Endurance Training ratio 1:1 (CT1)
Trial: 19516185
Drug: Amlodipine-perindopril therapy
RxNorm normalized name: amlodipine / perindopril
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amlodipine-perindopril therapy
Trial: 19516185
Drug: Atenolol-thiazide therapy
RxNorm normalized name: Atenolol
DrugBank: Atenolol (DB00335)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Atenolol-thiazide therapy
Trial: 15176293
Drug: Tuberculostatic drugs
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tuberculostatic drugs + vitamins C (1.0 g) and E (600 mg) after 1-month therapy
Trial: 15176293
Drug: Tuberculostatic drugs
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tuberculostatic drugs
Trial: 9724682
Drug: Urinary calcium
RxNorm normalized name: Urinary hCG
DrugBank: Chorionic Gonadotropin (Human) (DB09126)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Urinary calcium excretion measurement
Trial: 1785235
Drug: Unlimited access
RxNorm normalized name: sofosbuvir
DrugBank: Sofosbuvir (DB08934)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Unlimited access to oral water until 2 hours before anaesthesia
Trial: 7131548
Drug: Nicotine gum
RxNorm normalized name: Equate Nicotine Gum 4mg Starter Kit
DrugBank: Nicotine (DB00184)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nicotine gum (2 mg) for high-nicotine-dependent smokers
Trial: 7131548
Drug: Nicotine gum
RxNorm normalized name: Equate Nicotine Gum 4mg Starter Kit
DrugBank: Nicotine (DB00184)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nicotine gum (2 mg) for low-nicotine-dependent smokers
Trial: 22865999
Drug: Cognitive-motor exercise
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive-motor exercise program (twice weekly for 12 weeks) including strength and balance training and dance video gaming
Trial: 17479539
Drug: New retard
FDA approved: no
EMA approved: no
PMDA approved: no
Description: New retard tablet formulation of verapamil (240 mg oral dose)
Trial: 17479539
Drug: Standard retard
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard retard tablet formulation of verapamil (240 mg oral dose)
Trial: 17479539
Drug: Intravenous (i.v.)
RxNorm normalized name: immunoglobulins, intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous (i.v.) dose of verapamil (5 mg)
Trial: 9113177
Drug: 0.125 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.125 mg/kg morphine in 60 ml saline administered intravenously into the exsanguinated operative limb
Trial: 9113177
Drug: 60 ml
RxNorm normalized name: Disposable Nurser 60 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 60 ml saline administered intravenously into the operative leg and 0.125 mg/kg morphine intramuscularly into the opposite leg
Trial: 2580181
Drug: Captopril plus
RxNorm normalized name: Captopril
DrugBank: Captopril (DB01197)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Captopril plus a thiazide diuretic (37.5-75 mg/day)
Trial: 2580181
Drug: Propranolol plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol plus a diuretic (60-120 mg/day)
Trial: 2580181
Drug: Captopril plus
RxNorm normalized name: Captopril
DrugBank: Captopril (DB01197)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Captopril plus a thiazide diuretic
Trial: 2580181
Drug: Propranolol plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol plus a diuretic
Trial: 26599222
Drug: Potassium supplementation
RxNorm normalized name: Potassium
DrugBank: Potassium (DB14500)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Potassium supplementation (2.8 g/day)
Trial: 20410835
Drug: In-treatment EFS
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: In-treatment EFS
Trial: 20410835
Drug: In-treatment stress-corrected
FDA approved: no
EMA approved: no
PMDA approved: no
Description: In-treatment stress-corrected EFS
Trial: 20410835
Drug: In-treatment MWS
RxNorm normalized name: polyethyloxazoline (200000 MW)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: In-treatment MWS
Trial: 20410835
Drug: In-treatment stress-corrected
FDA approved: no
EMA approved: no
PMDA approved: no
Description: In-treatment stress-corrected MWS
Trial: 15943950
Drug: Buprenorphine/naloxone treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Buprenorphine/naloxone treatment in a Primary Care Clinic (PCC) for 26 weeks
Trial: 15943950
Drug: Methadone maintenance
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methadone maintenance treatment in an Opioid Treatment Program (OTP)
Trial: 29685792
Drug: Vitamin D3
RxNorm normalized name: Vitamin D3
DrugBank: Cholecalciferol (DB00169)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin D3 4000 IU daily for 12 months
Trial: 29685792
Drug: Vitamin D3
RxNorm normalized name: Vitamin D3
DrugBank: Cholecalciferol (DB00169)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin D3 2000 IU daily for 12 months
Trial: 27737356
Drug: Mandibular overdentures
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mandibular overdentures supported by two implants with bar‐clip system and a maxillary conventional denture (n = 25)
Trial: 27737356
Drug: Mandibular overdentures
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mandibular overdentures supported by two implants with bar‐clip system
Trial: 15772563
Drug: Conjugated equine
RxNorm normalized name: Conjugated equine estrogens
DrugBank: Conjugated estrogens (DB00286)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Conjugated equine estrogen 0.625 mg/d
Trial: 8082084
Drug: Tumors weighing
RxNorm normalized name: human breast tumor cell
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tumors weighing less than 550 g
Trial: 8082084
Drug: Tumors weighing
RxNorm normalized name: human breast tumor cell
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tumors weighing more than 550 g
Trial: 12501880
Drug: Once-daily alendronate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Once-daily alendronate 10 mg
Trial: 7673615
Drug: Lansoprazole 30
RxNorm normalized name: lansoprazole 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lansoprazole 30 mg/day for 8 weeks (GU) or 6 weeks (DU)
Trial: 7673615
Drug: Dual therapy
RxNorm normalized name: Tums Dual Action
DrugBank: Alginic acid (DB13518)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dual therapy of lansoprazole 30 mg/day and amoxicillin (AMPC) 1 g/day or clarithromycin (CAM) 400 mg/day for 2 weeks
Trial: 7673615
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy of lansoprazole 30 mg/day, AMPC 1 g/day, or CAM 400 mg/day, and metronidazole 500 mg/day for 2 weeks
Trial: 7032411
Drug: Metronidazole (single
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metronidazole (single intravenous dose)
Trial: 29898141
Drug: N‐acetylcysteine, vitamin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: N‐acetylcysteine, vitamin C and selenium (600 mg, 1500 mg, 0.5 mg respectively) administered orally twice a day from the day before to 2 days after surgery
Trial: 29898141
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (nothing administered)
Trial: 27227933
Drug: Sodium bicarbonate
RxNorm normalized name: Sodium Bicarbonate
DrugBank: Sodium bicarbonate (DB01390)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sodium bicarbonate (9 mL/kg bicarbonate 154 mmol/L)
Trial: 24703574
Drug: Pemetrexed 500
RxNorm normalized name: pemetrexed 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pemetrexed 500 mg/m² with vitamin B12 and folic acid q3w
Trial: 24703574
Drug: Pemetrexed 500
RxNorm normalized name: pemetrexed 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pemetrexed 500 mg/m² with vitamin B12 and folic acid q3w + Erlotinib 150 mg daily
Trial: 18235116
Drug: Imatinib (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Imatinib (100 to 800 mg daily)
Trial: 15881476
Drug: clarithromycin ER
RxNorm normalized name: Clarithromycin ER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: clarithromycin ER 1000 mg once daily
Trial: 12877665
Drug: Epoetin beta
RxNorm normalized name: Epoetin beta
DrugBank: Epoetin beta (DB19434)
FDA approved: no
EMA approved: yes
PMDA approved: no
Description: Epoetin beta 30,000 IU subcutaneously once weekly (q.w.)
Trial: 12877665
Drug: Epoetin beta
RxNorm normalized name: Epoetin beta
DrugBank: Epoetin beta (DB19434)
FDA approved: no
EMA approved: yes
PMDA approved: no
Description: Epoetin beta 10,000 IU three-times weekly (t.i.w.)
Trial: 7503620
Drug: verapamil 480
FDA approved: no
EMA approved: no
PMDA approved: no
Description: verapamil 480 mg/day
Trial: 7503620
Drug: metoprolol 200
RxNorm normalized name: metoprolol 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: metoprolol 200 mg/day
Trial: 1782922
Drug: Oral zinc
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral zinc sulphate 185.4 mg per day
Trial: 6890407
Drug: Scopolamine delivered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Scopolamine delivered by transdermal patch
Trial: 30565793
Drug: Donepezil (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Donepezil (10 mg/daily)
Trial: 24608196
Drug: NEPA100 +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NEPA100 + PALO 0.50 mg
Trial: 24608196
Drug: NEPA200 +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NEPA200 + PALO 0.50 mg
Trial: 24608196
Drug: NEPA300 +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NEPA300 + PALO 0.50 mg
Trial: 24608196
Drug: PALO 0.50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PALO 0.50 mg
Trial: 24608196
Drug: APR +
RxNorm normalized name: PrameGel Reformulated Apr 2012
FDA approved: no
EMA approved: no
PMDA approved: no
Description: APR + OND 32 mg
Trial: 19605373
Drug: Supervised aquatic
RxNorm normalized name: Mentha aquatica leaf extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Supervised aquatic training (3 weekly sessions of 60 min for 32 weeks)
Trial: 15751168
Drug: Dalteparin (5000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dalteparin (5000 IU, daily subcutaneous injections for 14 days)
Trial: 11788639
Drug: High-dose GH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose GH (100 mcg/kg/day)
Trial: 11788639
Drug: Post-GH treatment
RxNorm normalized name: post oak pollen extract
DrugBank: Quercus stellata pollen (DB10888)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Post-GH treatment
Trial: 10517552
Drug: Intravenous morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous morphine (MOR) administration
Trial: 10517552
Drug: Intrathecal morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intrathecal morphine (MOR) administration
Trial: 109598
Drug: Test regimen
RxNorm normalized name: Anacin Aspirin Regimen Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Test regimen of prednisone therapy (higher dosage, longer duration)
Trial: 28673323
Drug: Bracelet- and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bracelet- and self-directed observational therapy (BSDOT)
Trial: 26519114
Drug: Aldosterone antagonist
RxNorm normalized name: Aldosterone antagonists
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aldosterone antagonist (spironolactone) in combination with RAAS blockers
Trial: 26519114
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (RAAS blockers only)
Trial: 21170603
Drug: Cr brewer's
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cr brewer's yeast supplementation (500 μg Cr/person/day)
Trial: 17200492
Drug: 25 mg/day
RxNorm normalized name: estradiol 0.025 MG/Day Transdermal System
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25 mg/day of zonisamide (ZNS)
Trial: 17200492
Drug: 50 mg/day
RxNorm normalized name: infigratinib phosphate 50 mg/day (25 mg x 2) ORAL CAPSULE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg/day of zonisamide (ZNS)
Trial: 17200492
Drug: 100 mg/day
RxNorm normalized name: infigratinib phosphate 100 mg/day (100 mg x 1) ORAL CAPSULE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg/day of zonisamide (ZNS)
Trial: 2459557
Drug: Penticainide (1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Penticainide (1.5 mg/kg)
Trial: 2459557
Drug: Disopyramide (1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Disopyramide (1.5 mg/kg)
Trial: 31830433
Drug: Knee brace
RxNorm normalized name: Knee Brace Large
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Knee brace for 2 weeks during daily living, sports, or painful tasks
Trial: 26368295
Drug: Methadone 10
RxNorm normalized name: normethadone 10 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methadone 10 mg (oral dose)
Trial: 21292898
Drug: Intermittent preventive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intermittent preventive treatment in pregnancy (IPTp) with sulfadoxine pyrimetamine (SP)
Trial: 16856588
Drug: Only vaginal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Only vaginal misoprostol (400 microg 6 hourly up to 4 doses)
Trial: 16856588
Drug: Oral plus
RxNorm normalized name: Acetaminophen/Dexbrompheniramine Maleate/Pseudoephedrine Hydrochloride 500 MG-3 MG-60 MG Oral Tablet, Extended Release [DRIXORAL PLUS]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral plus vaginal misoprostol (400 microg orally at 12 hour intervals for 2 doses, followed by 400 microg vaginally 6 hourly up to 4 doses)
Trial: 14551000
Drug: Food and
RxNorm normalized name: ThickenUp Clear Instant Food and Beverage Thickener Powder
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Food and Drug Administration table with numbers
Trial: 11018309
Drug: Lipo PGE1
RxNorm normalized name: PGE1
DrugBank: Alprostadil (DB00770)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lipo PGE1 injection
Trial: 11018309
Drug: Constant rate
RxNorm normalized name: constant albicans extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Constant rate infusion of PGE1 (10 ng kg(‐1) min(‐1))